Alto Neuroscience, Inc. (ANRO)
18.30
+0.68
(+3.86%)
USD |
NYSE |
Feb 23, 16:00
18.31
+0.01
(+0.05%)
Pre-Market: 19:59
Alto Neuroscience EPS Diluted (Quarterly) : -0.5232 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | -1.203 |
| Vertex Pharmaceuticals, Inc. | 4.651 |
| Fortress Biotech, Inc. | 0.111 |
| Oramed Pharmaceuticals, Inc. | 1.131 |
| Replimune Group, Inc. | -0.7694 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.18M |
| Total Expenses (Quarterly) | 14.18M |
| Enterprise Value | 458.22M |
| Earnings Yield | -12.58% |
| Normalized Earnings Yield | -12.45 |